General Information
Version
8.3
Revision date
2023-02-26
Product name
Cholera Toxin, Vibrio cholerae, Type Inaba
REACH No
This
1.2.1 Relevant identified uses
Biochemical research/analysis
Emergency telephone
+(353)-19014670
Icons in SDS
Company Information
company name
Sigma-Aldrich Ireland Limited
e-mail address of the competent person responsible for the Safety Data Sheet
TechnicalService@merckgroup.com
GHS Information
Signal word
Danger
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
Classification
2.2 Label elements
Labelling
Signal word
Danger Danger
Hazard statements
H300 + H310 Fatal if swallowed or in contact with skin. H315 Causes skin irritation. Reduced Labeling (<= 125 ml) H300 + H310 Fatal if swallowed or in contact with skin.
Precautionary statements
P262 Do not get in eyes, on skin, or on clothing. P264 Wash skin thoroughly after handling. P270 Do not eat, drink or smoke when using this product. P280 Wear protective gloves/ protective clothing. P301 + P310 IF SWALLOWED: Immediately call a POISON CENTER/ doctor. P302 + P352 + P310 IF ON SKIN: Wash with plenty of water. Immediately call a POISON CENTER/ doctor. P262 Do not get in eyes, on skin, or on clothing. P264 Wash skin thoroughly after handling. P270 Do not eat, drink or smoke when using this product. P280 Wear protective gloves/ protective clothing. P301 + P310 IF SWALLOWED: Immediately call a POISON CENTER/ doctor. P302 + P352 + P310 IF ON SKIN: Wash with plenty of water. Immediately call a POISON CENTER/ doctor.
Supplemental label elements
none none
2.3 Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher. SECTION 3: Composition/information on ingredients 3.2 Mixtures Component
Classifications
Concentration Exotoxin, vibrio cholerae CAS-No. 9012-63-9 Acute Tox. 1; H300, H310 >= 90 - <= 100 % * *A registration number is not available for this substance as the substance or its use are exempted from registration according to Article 2 REACH Regulation